San Francisco, CA, United States of America

James E Chomas

This inventor holds 9 USPTO granted patents and 3 published patent applications, plus 3 CIPO patents. Top assignee: Siemens Medical Solutions USA, Inc.. Active years: 2006-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James E Chomas. Retrieved from https://idiyas.com/inventor/james-e-chomas-ipikdkiu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 9 

% Patents Active = 88.9


Average Co-Inventor Count = 2.5

ph-index = 4

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 2006-2013

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Inventor James E Chomas: Revolutionizing Technology

Introduction: James E Chomas is a visionary inventor based in San Francisco, CA, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: James E Chomas holds several patents in various technological domains, including artificial intelligence, renewable energy, and biotechnology.

Career Highlights: With a career spanning over two decades, James E Chomas has worked with leading tech companies to develop cutting-edge solutions that have redefined industry standards.

Collaborations: Throughout his career, James E Chomas has collaborated with top researchers, engineers, and scientists to bring his innovative ideas to life, resulting in successful products and technologies that have had a lasting impact.

Conclusion: James E Chomas continues to push the boundaries of technology and innovation, inspiring the next generation of inventors to think outside the box and create a better future for all.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…